Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach

Molecular Human Reproduction

Volumn 13, Issue 1, 2007, Pages 61-67

  Johnson, M P ^a   Fitzpatrick, E ^b   Dyer, T D ^a   Jowett, J B M ^c,d   Brennecke, S P ^b   Blangero, J ^a   Moses, E K ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d ChemGenex Pharmaceuticals   (Australia)

Author keywords

Genome scan; Linkage; Pre eclampsia; Quantitative trait; Variance components

Indexed keywords

AMINOPEPTIDASE; COLLAGEN TYPE 4; PLACENTAL PEPTIDE HORMONE;

ARTICLE; AUSTRALIA; BIOINFORMATICS; CHROMOSOME 13Q; CHROMOSOME 5Q; COMPUTER PROGRAM; CONTROLLED STUDY; ECLAMPSIA; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HERITABILITY; HUMAN; HUMAN CELL; LINKAGE ANALYSIS; NEW ZEALAND; PATHOGENESIS; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS MAPPING; SCORING SYSTEM;

ANALYSIS OF VARIANCE; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); LOD SCORE; PRE-ECLAMPSIA; PREGNANCY; QUANTITATIVE TRAIT LOCI; QUANTITATIVE TRAIT, HERITABLE;

EID: 33845680776     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal095     Document Type: Article

References (57)

1. Allison DB, Heo M, Kaplan N and Martin ER (1999) Sibling-based tests of linkage and association for quantitative traits. Am J Hum Genet 64,1754-1763.
2. Almasy L and Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62,1198-1211.
3. Arngrimsson R, Sigurard ttir S, Frigge ML, Bjarnad ttir RI, Jonsson T, Stefansson H, Baldursdottir A, Einarsdottir AS, Palsson B, Snorradottir S et al. (1999) A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 8,1799-1805.
4. Bjorn SF, Hastrup N, Lund LR, Dano K, Larsen JF and Pyke C (1997) Coordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation. Mol Hum Reprod 3,713-723.
5. Blangero J, Williams JT and Almasy L (2000) Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol 19 (Suppl 1),S8-S14.
6. Blangero J, Williams JT and Almasy L (2001) Variance component methods for detecting complex trait loci. Adv Genet 42,151-181.
7. Brown MA, Gallery EDM, Gatt SP, Leslie G and Robinson J (1993) Management of hypertension in pregnancy: Executive summary. Med J Aust 158,700-702.
8. Campbell EA, Liston EA, Wolfe CD, Scraggs PR, Jones MT and Lowry PJ (1987) Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 64,1054-1059.
9. Carr DB, Epplein M, Johnson CO, Easterling TR and Critchlow CW (2005) A sister's risk: Family history as a predictor of preeclampsia. Am J Obstet Gynecol 193,965-972.
10. Dekker G and Sibai B (2001) Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 357,209-215.
11. van Dijk M, Mulders J, Poutsma A, Konst AA, Lachmeijer AM, Dekker GA, Blankenstein MA and Oudejans CB (2005) Maternal segregation of the Dutch preeclampsia locus at lOq22 with a new member of the winged helix gene family. Nat Genet 37,514-519.
12. Dyke B (1989) PEDSYS. A Pedigree Data Management System. Users Manual. In PGL Technical Report, no. 2. Southwest Foundation for Biomedical Research, San Antonio, Texas.
13. Fitzpatrick E, Goring HH, Liu H, Borg A, Forrest S, Cooper DW, Brennecke SP and Moses EK (2004) Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum Biol 76,849-862.
14. Fulker DW and Cardon LR (1994) A sib-pair approach to interval mapping of quantitative trait loci. Am J Hum Genet 54,1092-1103.
15. Fulker DW, Cherny SS and Cardon LR (1995) Multipoint interval mapping of quantitative trait loci, using sib pairs. Am J Hum Genet 56,1224-1233.
16. Harrison GA, Humphrey KE, Jones N, Badenhop R, Guo G, Elakis G, Kaye JA, Turner RJ, Grehan M, Wilton AN et al. (1997) A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 60,1158-1167.
17. Hattori A, Kitatani K, Matsumoto H, Miyazawa S, Rogi T, Tsuruoka N, Mizutani S, Natori Y and Tsujimoto M (2000) Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. J Biochem (Tokyo) 128,755-762.
18. Hattori A, Matsumoto K, Mizutani S and Tsujimoto M (2001) Genomic organization of the human adipocyte-derived leucine aminopeptidase gene and its relationship to the placental leucine aminopeptidase/oxytocinase gene. J Biochem (Tokyo) 130,235-241.
19. Hayward C, Livingstone J, Holloway S, Liston WA and Brock DJ (1992) An exclusion map for pre-eclampsia: Assuming autosomal recessive inheritance. Am J Hum Genet 50,749-757.
20. Heath SC (1997) Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 61,748-760.
21. Heath SC, Snow GL, Thompson EA, Tseng C and Wijsman EM (1997) MCMC segregation and linkage analysis. Genet Epidemiol 14,1011-1016.
22. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, VanDorsten JP, Landon M, Miodovnik M, Paul R et al. (2002) Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 186,422-426.
23. Ino K, Kikkawa F, Suzuki T, Kajiyama H, Shibata K, Nomura S, Itakura A, Ito M, Nagasaka T, Hattori A et al. (2003) Expression of placental leucine aminopeptidase and adipocyte-derived leucine aminopeptidase in human normal and malignant invasive trophoblastic cells. Lab Invest 83,1799-1809.
24. Jauniaux E, Poston L and Burton GJ (2006) Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update 12,747-755.
25. Kaufmann P, Black S and Huppertz B (2003) Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69,1-7.
26. Kong A and Cox NJ (1997) Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61,1179-1188.
27. Kruglyak L, Daly MJ, Reeve-Daly MP and Lander ES (1996) Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58,1347-1363.
28. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Frigge ML, Pals G, Sigurdardottir S, Stefansson H, Palsson B, Nicolae D, Kong A et al. (2001) A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet 9,758-764.
29. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP and Arngrimsson R (2002) Searching for preeclampsia genes: The current position. Eur J Obstet Gynecol Reprod Biol 105,94-113.
30. Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, Laitinen T, Kaaja R, Ylikorkala O and Kere J (2003) Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet 72,168-177.
31. Lander ES and Green P (1987) Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci USA 84,2363-2367.
32. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E and Irgens LM (1998) Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 316,1343-1347.
33. Matsumoto H, Rogi T, Yamashiro K, Kodama S, Tsuruoka N, Hattori A, Takio K, Mizutani S and Tsujimoto M (2000) Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur J Biochem 267,46-52.
34. McLean M, Bisits A, Davies J, Woods R, Lowry P and Smith R (1995) A placental clock controlling the length of human pregnancy. Nat Med 1,460-463.
35. Mizutani S, Akiyama H, Kurauchi O, Taira H, Narita O and Tomoda Y (1985) Plasma angiotensin I and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia. Arch Gynecol 236,165-172.
36. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW et al. (2000) A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 67,1581-1585.
37. Moses EK, Fitzpatrick E, Freed KA, Dyer TD, Forrest S, Elliott K, Johnson MP, Blangero J and Brennecke SP (2006) Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod 12,505-512.
38. Myatt L and Miodovnik M (1999) Prediction of preeclampsia. Semin Perinatol 23,45-57.
39. Nilsson E, Salonen Ros H, Cnattingius S and Lichtenstein P (2004) The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: A family study. BJOG 111,200-206.
40. O'Brien TE, Ray JG and Chan WS (2003) Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology 14,368-374.
41. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA and Austgulen R (2000) Risk factors and clinical manifestations of pre-eclampsia. BJOG 107,1410-1416.
42. Oudejans CB, Mulders J, Lachmeijer AM, van Dijk M, Konst AA, Westerman BA, van Wijk IJ, Leegwater PA, Kato HD, Matsuda T et al. (2004) The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol Hum Reprod 10,589-598.
43. Pang ZJ and Xing FQ (2003) Expression profile of trophoblast invasion-associated genes in the pre-eclamptic placenta. Br J Biomed Sci 60,97-101.
44. Perkins AV, Eben F, Wolfe CD, Schulte HM and Linton EA (1993) Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J Endocrinol 138,149-157.
45. Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD and Redman CW (1995) Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 102,118-122.
46. Petraglia F, Aguzzoli L, Gallinelli A, Florio P, Zonca M, Benedetto C and Woodruff K (1995) Hypertension in pregnancy: Changes in activin A maternal serum concentration. Placenta 16,447-454.
47. Salonen Ros H, Lichtenstein P, Lipworth L and Cnattingius S (2000) Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 91,256-260.
48. Sasaki A, Liotta AS, Luckey MM, Margioris AN, Suda T and Krieger DT (1984) Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J Clin Endocrinol Metab 59,812-814.
49. Self SG and Liang KY (1987) Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assoc 82,605-610.
50. Sibai BM (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100,369-377.
51. Sibai B, Dekker G and Kupferminc M (2005) Pre-eclampsia. Lancet 365,785-799.
52. Sobel E and Lange K (1996) Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58,1323-1337.
53. Sobel E, Sengul H and Weeks DE (2001) Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees. Hum Hered 52,121-131.
54. Tsujimoto M, Mizutani S, Adachi H, Kimura M, Nakazato H and Tomoda Y (1992) Identification of human placental leucine aminopeptidase as oxytocinase. Arch Biochem Biophys 292,388-392.
55. Wewer UM, Faber M, Liotta LA and Albrechtsen R (1985) Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells. Lab Invest 53,624-633.
56. Williams JT, Van Eerdewegh P, Almasy L and Blangero J (1999) Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. Am J Hum Genet 65,1134-1147.
57. World Health Organization (2002) Chapter 2: Making pregnancy safer. Biennial report UNCP/UNFPA/WH0/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. World Health Organization, Geneva, Switzerland, pp. 25-30.